期刊文献+

单中心中国初诊前列腺癌患者骨转移预测因素分析 被引量:3

Independent predictors of bone metastases at the initial stage of prostate cancer diagnosis:a single center analysis in Chinese patients
下载PDF
导出
摘要 目的界定国人初诊前列腺癌患者骨转移高危因素,初步确定骨转移极低风险患者特征。方法收集2010年至2015年在第二军医大学长海医院初次确诊的496例前列腺癌患者的临床资料。所有患者确诊后均行^(99m)Tc MDP注射的全身骨骼ECT扫描。分析所有患者确诊时的年龄、穿刺前末次前列腺特异抗原(PSA)、临床T分期、前列腺穿刺Gleason评分及骨扫描、相应MRI/CT结果。用单因素及多因素logistic回归方法得出预测骨转移的相关临床指标。结果 496例患者中,81例(16.3%)存在骨转移。骨转移组与无骨转移组的年龄无差异,但骨转移组患者PSA水平大于无骨转移组(P<0.001)。随着PSA水平、临床T分期或穿刺Gleason评分升高,骨转移风险增大(P<0.001)。单因素logistic回归分析显示,穿刺前PSA>20ng/mL、临床T分期为T3~T4和活检Gleason评分≥8是骨转移的影响因素。多因素logistic回归显示,PSA>50ng/mL和活检Gleason评分≥8是骨转移的独立预测因素。初诊PSA≤20ng/mL且Gleason评分≤6的79例前列腺癌患者无一例出现骨转移。结论初诊PSA≤20ng/mL且Gleason评分≤6的中国前列腺癌患者骨转移发生率非常低,这部分患者在初诊时不需要行骨扫描检查。 Objective To indentify the high risk factors of bone metastasis in Chinese patients at the initial stage of prostate cancer (PCa) diagnosis, so as to elucidate the characteristics of patients with very low risk of bone metastasis at the initial stage of prostate cancer. Methods A consecutive series of 496 patients with newly diagnosed PCa between 2010 and 2015 were enrolled in the present study. All the patients were subjected to ECT scan for presence of bone metastasis (BM) using total-body 99mWc MDP scintigraphy regardless of baseline PCa characteristics. Factors including the age of diagnosis, prostate specific antigen (PSA) level at diagnosis, Gleason score, clinical T stage, bone scan and CT/MRI results were analyzed. Univariate and multivariate logistic regression analyses were performed to identify the predictors of bone metastases. Results Of the 496 patients, 81 patients (16. 3%) had bone metastases. The PSA levels of patients with BM were significantly higher than those without BM (P〈0. 001). The mean age of the patients with BM was not significantly older than that of the patients without BM. Patients with higher PSA level, clinical T stage or Gleason score showed a significantly higher risk of BM (P〈0. 001). Univariate logistic regression analysis showed that PSA〉20 ng/mL at diagnosis, clinical stage at T3-T4 and Gleason score≥8 were the risk factors of bone metastasis in PCa patients. The multivariate analysis showed that the PSA level〉50 ng/ mL and the Gleason score≥8 were the independent predictors of bone metastases. No bone metastasis was found in 79 patients with PSA≤20 ng/mL and at the same time with Gleason score≤6. Conclusion The bone metastases rate is very low in Chinese patients with a PSA level ≤20 ng/mL and at the same time with Gleason score≤6, so a bone scan is not necessary as a routine for these patients with newly diagnosed prostate cancer.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2016年第1期5-9,共5页 Academic Journal of Second Military Medical University
基金 国家自然科学基金(81172076)~~
关键词 前列腺肿瘤 骨转移 前列腺特异抗原 危险因素 prostatic neoplasms bone metastasis prostate-specific antigen risk factors
  • 相关文献

参考文献25

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013[J]. CA Cancer J Clin, 2013,63:11-30.
  • 2Center M M, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, et al. International variation in prostate cancer incidence and mortality rates[J]. Eur Uurol,2012,61:1079-1092.
  • 3全国肿瘤防治研究办公室卫生部疾病预防控制局. 中国肿瘤登记年报2004[M].北京:中国协和医科大学出版社,2008.
  • 4赫捷,赵平,陈万青.2012中国肿瘤登记年报[M].北京:军事医学科学出版社,2013:15.
  • 5Lai M H, Luk W H, Chan J C. Predicting bone scan findings using sPSA in patients newly diagnosed of prostate cancer: feasibility in Asian population[J]. Urol Oncol,2011,29:275-279.
  • 6Gallina A, Chun F K, Suardi N, Eastham J A, Perrotte P, Graefen M, et al. Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer[J]. BJU Int, 2008,101:1513-1518.
  • 7Ryan C J, Elkin E P, Small E J, Duchane J, Carroll P. Reduced incidence of bony metastasis at initial prostate cancer diagnosis: data from CaPSURE[J]. Urol Oncol,2006,24:396-402.
  • 8Wang Y, Guo J, Xu L, Zhao N, Xu Z, Wang H, et al. Should bone scan be performed in Chinese prostate cancer patients at the time of diagnosis[J]. Urol Int, 2013,91:160-164.
  • 9Clinical recommendations[EB/OL].[2015-12-25]http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
  • 10Thompson I, Thrasher J B, Aus G, Burnett A L, Canby-Hagino E D, Cookson M S, et al. Guideline for the management of clinically localized prostate cancer: 2007 update[J]. J Urol,2007,177:2106-2131.

二级参考文献19

  • 1Choi IY, Park S, Park B, et al. Development of prostate cancer research database with the clinical data warehouse technology for direct linkage with electronic medical record system [ J ]. Prostate Int ,2013,1:59-64.
  • 2Bott SR,Henderson A, Parkinson MC, et al. Setting up a prostate cancer database:experiences on how to get out more than you put in[ J]. BJU Int,2003 ,92 :665-666.
  • 3Lubeck DP, Litwin MS, Henning JM, et al. The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE research panel. Cancer of the Prostate Strategic Urologic Research Endeavor[ J]. Urology, 1996,48:773- 777.
  • 4Porten SP, Cooperberg MR, Konety BR, et al. The example of CaPSURE: lessons learned from a national disease registry [ J ]. World J Urol,2011,29:265-271.
  • 5Peyromaure M, Debre B, Mao K, et al. Management of prostate cancer in China:a muhicenter report of 6 institutions[ J]. J Urol, 2005,174 : 1794-1797.
  • 6Gao X, Ren S,Lu X,et al. The newer the better? Comparison of the 1997 and 2001 Partin tables for pathologic stage prediction of prostate cancer in China[ J]. Urology,2008,72 : 1096-1101.
  • 7Punnen S, Cowan JE, Chan JM, et al. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry[ J/OL]. Eur Urol,2014 [ 2015- 05-07 ] . http ://www. linkinghub, elsevier, com/retrieve/pii/ S0302-2838 ( 14 ) 00844-00846.
  • 8Akaza H,Hinotsu S,Cooperberg MR, et al. Sixth joint meeting of J-CaP and CaPSURE-a multinational perspective on prostate cancer management and patient outcomes[ J]. Jpn J Clin Oncol, 2013,43:756-766.
  • 9Cary KC, Paeiorek A, Fuldeore M J, et al. Temporal trends and predictors of salvage cancer treatment after failure following radical prostatectomy or radiation therapy:an analysis from the CaPSURE registry[ J ]. Cancer,2014,1204:507-512.
  • 10Di Pisa F, Mastrangelo D, Hadjistilianou T, et al. Design and implementation of a relational database used in the management of patients with retinoblastoma[ J ]. Comput Biomed Res, 1997,30 : 273 -289.

共引文献25

同被引文献29

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部